TREA

97822178 - PROTAGONIST THERAPEUTICS

Follow

Information

  • Trademark
  • 97822178
  • Serial Number
    97822178
  • Filing Date
    March 03, 2023
    a year ago
  • Transaction Date
    October 11, 2024
    4 months ago
  • Status Date
    October 11, 2024
    4 months ago
  • Published for Opposition Date
    August 29, 2023
    a year ago
  • Location Date
    October 24, 2023
    a year ago
  • First Use Anywhere Date
    August 22, 2006
    18 years ago
  • First Use In Commerce Date
    August 22, 2006
    18 years ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    HA, PAULINE
  • Attorney Docket Number
    4230-T4US
    Attorney Name
    Frances M. Jagla
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
PROTAGONIST THERAPEUTICS
Case File Statements
  • GS0051: Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of metabolic disorders
  • GS0441: Providing healthcare information to healthcare professionals and patients relating to disease states and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
  • DS0000: "THERAPEUTICS"
  • GS0421: Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Scientific research, pharmaceutical research, medical research; technical consultation services in the field of research and product development for the treatment of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; scientific consultation services in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; product development services for others in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, oncological and rare diseases
Case File Event Statements
  • 6/25/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/7/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/23/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/3/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/3/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/3/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/17/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/17/2023 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/18/2023 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/20/2023 - a year ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/29/2023 - a year ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/24/2023 - a year ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/9/2023 - a year ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/29/2023 - a year ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/12/2024 - 11 months ago
    17 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 3/12/2024 - 11 months ago
    16 - SOU EXTENSION 1 FILED Type: EXT1
  • 3/12/2024 - 11 months ago
    15 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/11/2024 - 4 months ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/11/2024 - 4 months ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/11/2024 - 4 months ago
    20 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/11/2024 - 4 months ago
    21 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 3/13/2024 - 11 months ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA